Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeloda + Oxaliplatin in Metastatic Nasopharyngeal Cancer
NCT00439426Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2007
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in nasopharyngeal carcinoma (NPC), sponsored by Roche. Started Apr 2007; status: completed.
02
Drugs
capecitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00439426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439426.